Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/20/25
End: 12/30/29
Due: 12/30/30
Phase: N/A
Priority: Normal
Start: 05/05/23
End: 05/23/26
Due: 05/23/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors | NCT06953323 | Wigen Biomedicine Technology (Shanghai) Co., Ltd. | user2@example.com | None | 2025-05-20 | 2029-12-30 | 2030-12-30 | - | - | 2025-07-14 |
| A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors | NCT05773820 | Wigen Biomedicine Technology (Shanghai) Co., Ltd. | user2@example.com | None | 2023-05-05 | 2026-05-23 | 2027-05-23 | - | - | 2025-07-14 |